ArticleObesity surgery2026
Laparoscopic Transcystic Common Bile Duct Exploration for the Treatment of Choledocholithiasis Following Roux-en-Y Gastric Bypass.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCholedocholithiasis is challenging to treat in patients who have undergone Roux-en-Y gastric bypass (RYGB). Laparoscopic transcystic common bile duct exploration (LTCBDE) performed at the time of the cholecystectomy is an alternative treatment modality that has the potential to reduce hospital length of stay (LOS) and postoperative morbidity.
methodsThis is an IRB-approved, single-academic institution retrospective cohort study analyzing electronic medical records of patients with RYGB anatomy who underwent LTCBDE for choledocholithiasis between 2021 and 2025. The primary outcome of interest was procedural response. Secondary outcomes of interest included technical response rates, operative and 30-day postoperative complications. Hospital and postoperative LOS were compared between admitting services.
resultsNineteen patients with RYGB anatomy underwent LTCBDE and concomitant cholecystectomy. Technical response was achieved in 100% of patients, and procedural response was achieved in 94.7% of patients. One (5.3%) required an additional procedure after a retained stone was found incidentally on cross-sectional imaging for oncologic surveillance purposes. No intraoperative or postoperative complications were experienced. Patients admitted to a surgical service had a shorter hospital LOS by 3.1 days on average (P < 0.001; 95% CI -1.2,-2.6) and median postoperative LOS by 0.3 days (P = 0.035; 95% CI -0.1,-1.6) than those admitted to a medicine service.
conclusionsOur data demonstrate high rates of technical and procedural response with no complications, and a shorter overall hospital LOS when managed by a surgical team, supporting the use of LTCBDE to treat choledocholithiasis in patients with RYGB anatomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.